L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
LA ROCHE-POSAY AT IMCAS 2024
IMCAS 2024: Practice management of Melasma
Watch Dr. Hassan GALADARI at IMCAS World Congress 2024 as he discusses the practice management of patients with melasma, from pathogenesis to treatment options.
Presented Posters
Discovery of 2-mercapto nicotinoyl glycine
A new potent skin lightening agent with a proven clinical efficacy
Melanin production inhibitors currently marketed tyrosinase, the rate limiting enzyme in melanin synthesis process. Yet only a few have demonstrated clinical efficacy while some present safety issues.
2-Mercaptonicotinoyl glycine: a new molecule that prevents and decreases uv-induced pigmentation.
Hyperpigmentation disorders are a frequent reason for dermatology consultations as they can impair quality of life.
A topical formula containing proxylane and niacinamide augments the anti-ageing benefits of a non-ablative laser treatment
Minimally invasive aesthetic procedures, such as microneedling and non-ablative laser treatment, are rapidly increasing in popularity due to minimal recovery and downtime with effective results for skin rejuvenation.
Pigmentary disorders, prevalence, impact on quality of life, social stigmatization: Results of the first large international survey
Pigmentary disorders (PD) such as Melasma, Post-inflammatory Hyperpigmentation (PIH), Solar Lentigo, Peri-Orbital Hyperpigmentation (POH) and Axillary Hyperpigmentation (AH) are frequent dermatological conditions, but little is known on their real-world prevalence and impact.